Increased serum concentration of apolipoprotein B is associated with an increased risk of reaching renal replacement therapy in patients with diabetic kidney disease

Few studies have investigated the association of apolipoprotein B (ApoB) with the progression of diabetic kidney disease (DKD) and the risk of renal replacement therapy (RRT). In this retrospective cohort study, a group of 258 DKD patients with stage 3-5chronic kidney disease(CKD)were divided into l...

Full description

Saved in:
Bibliographic Details
Published in:Renal failure 2020-01, Vol.42 (1), p.323-328
Main Authors: Zhao, Wen-bo, Zhu, Lin, Rahman, Tohty
Format: Article
Language:English
Subjects:
Adult
Aged
Aged, 80 and over
Apolipoprotein B
Apolipoproteins
Apolipoproteins B - blood
China
chronic kidney disease
Clinical Study
Diabetes
Diabetes mellitus
Diabetic kidney disease
Diabetic Nephropathies - complications
Disease Progression
Female
Humans
Kaplan-Meier Estimate
Kidney diseases
Male
Middle Aged
Multivariate Analysis
Prognosis
Proportional Hazards Models
Renal Insufficiency, Chronic - blood
Renal Insufficiency, Chronic - therapy
Renal replacement therapy
Renal Replacement Therapy - statistics & numerical data
Retrospective Studies
Risk Factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Few studies have investigated the association of apolipoprotein B (ApoB) with the progression of diabetic kidney disease (DKD) and the risk of renal replacement therapy (RRT). In this retrospective cohort study, a group of 258 DKD patients with stage 3-5chronic kidney disease(CKD)were divided into low ApoB (
ISSN:0886-022X
1525-6049
DOI:10.1080/0886022X.2020.1745235